Close Menu

The Wall Street Journal reports on how Procter & Gamble has made use of genomic advances with "new ways to develop dandruff shampoo, skin cream and toothpaste," the story says. The work began a decade ago and today, "those efforts are starting to hit store shelves." Exhibit A: Olay Pro-X, a skin cream that P&G scientists say is based on gene expression studies to determine the differences between old and young skin, and how to make the former appear like the latter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.